Company intelligence / Profile preview

Hainan Shuangcheng Pharmaceuticals

Haikou, Hainan, Chinashuangchengmed.com ↗
Ownership
Private
Employees
~474
Development stage
Commercial
01

Overview

Publicly-traded Chinese pharma company specializing in peptide APIs and generic drugs, with FDA/EU-certified manufacturing facilities and CDMO services

Therapeutic areas
GastroenterologyEndocrinologyOncologyOther
Modalities
Synthetic peptidesSmall moleculesGeneric finished dosages
Industry
Biotech
02

Drug pipeline

3 assets

SCB101-DD

Preclinical

2 more assets in the full pipeline.

03

Partnerships

Yichang Humanwell Pharmaceutical Co.

Beyond the preview

Go deeper on Hainan Shuangcheng Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hainan Shuangcheng Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call